Athelas Incorporated

RenovoRx is a life sciences company dedicated to developing innovative targeted oncology therapies, focusing on addressing high unmet medical needs in cancer treatment. Their flagship product, RenovoCath, is an FDA-cleared drug-delivery device designed to enhance the intra-arterial administration of chemotherapy, specifically targeting locally advanced pancreatic cancer. The company's proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform aims to improve the effectiveness and safety of cancer therapies by delivering treatment directly to tumor sites while minimizing systemic side effects. Currently, RenovoRx is conducting a Phase III clinical trial, TIGeR-PaC, to evaluate the efficacy of its combination oncology product candidate against standard intravenous chemotherapy options. Generated from the website

Intuitive Surgical is a global technology leader in the field of robotic-assisted, minimally invasive surgery. The company develops, manufactures and markets robotic technologies designed to improve clinical outcomes and help patients return more quickly to active lives. Its patented da Vinci Surgical System is a sophisticated robotic platform designed to enable complex surgery using a minimally invasive approach. The da Vinci Surgical System is utilized worldwide, in major centers in the United States, Austria, Belgium, Canada, Denmark, France, Germany, Italy, India, Japan, the Netherlands, Romania, Saudi Arabia, Singapore, Sweden, Switzerland, United Kingdom, Australia and Turkey. Intuitive Surgical has headquarters in Sunnyvale, Calif.

Relievant Medsystems Inc, based in Sunnyvale, CA, is a leading medical technology company dedicated to providing relief for chronic low back pain. With a patient-centered mission, they offer the proven and durable Intracept Procedure, backed by 30 years of scientific research and clinical evidence, to treat millions of patients suffering from vertebrogenic pain. Through their innovative approach and advanced technology, Relievant Medsystems aims to improve and expand physician training opportunities, ensuring effective treatment for vertebrogenic low back pain. With positive coverage policies from major insurance providers, they are committed to bringing lasting relief and transforming the lives of patients who have experienced the life-changing benefits of the Intracept Procedure.Generated from the website